Literature DB >> 18284466

Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects.

Karina I Carvalho1, Solange Maeda, Luciana Marti, Jane Yamashita, Patrick A J Haslett, Esper G Kallas.   

Abstract

Leprosy and human immunodeficiency virus-1 (HIV-1) are examples of human infections where interactions between the pathogen and the host cellular immunity determine the clinical manifestations of disease. Hence, a significant immunopathological interaction between HIV-1 and leprosy might be expected. In the present study we explored several aspects of cellular immunity in patients co-infected with HIV-1 and Mycobacterium leprae. Twenty-eight individuals were studied, comprising four groups: healthy controls, HIV-1 and M. leprae co-infection, HIV-1 mono-infection, and M. leprae mono-infection. Subjects in the mono-infection and co-infection groups were matched as far as possible for bacillary load and HIV disease status, as appropriate. Peripheral blood mononuclear cells (PBMC) were analysed using six- and seven-colour flow cytometry to evaluate T-cell subpopulations and their activation status, dendritic cell (DC) distribution phenotypes and expression of IL-4 by T cells. The co-infected group exhibited lower CD4 : CD8 ratios, higher levels of CD8(+) T-cell activation, increased V delta : V delta 2 T cell ratios and decreased percentages of plasmacytoid DC, compared with HIV-1 mono-infected subjects. Across infected groups, IL-4 production by CD4(+) T lymphocytes was positively correlated with the percentage of effector memory CD4(+) T cells, suggesting antigenically driven differentiation of this population of T cells in both HIV-1 and M. leprae infections. Co-infection with M. leprae may exacerbate the immunopathology of HIV-1 disease. A T helper 2 (Th2) bias in the CD4(+) T-cell response was evident in both HIV-1 infection and leprosy, but no additive effect was apparent in co-infected patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18284466      PMCID: PMC2566625          DOI: 10.1111/j.1365-2567.2007.02756.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  43 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Bulk cytokine production versus frequency of cytokine-producing cells in HIV1 infection before and during HAART.

Authors:  A E Sousa; A F Chaves; M Doroana; F Antunes; R M Victorino
Journal:  Clin Immunol       Date:  2000-11       Impact factor: 3.969

3.  Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats.

Authors:  M Roederer
Journal:  Cytometry       Date:  2001-11-01

Review 4.  Innate T-cell immunity in HIV infection: the role of Vgamma9Vdelta2 T lymphocytes.

Authors:  F Poccia; M L Gougeon; C Agrati; C Montesano; F Martini; C D Pauza; P Fisch; M Wallace; M Malkovsky
Journal:  Curr Mol Med       Date:  2002-12       Impact factor: 2.222

5.  Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients.

Authors:  Z Toossi; H Mayanja-Kizza; C S Hirsch; K L Edmonds; T Spahlinger; D L Hom; H Aung; P Mugyenyi; J J Ellner; C W Whalen
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

6.  The effect of antigen presenting cells on the cytokine profiles of stable and reactional lepromatous leprosy patients.

Authors:  I Nath; N Vemuri; A L Reddi; S Jain; P Brooks; M J Colston; R S Misra; V Ramesh
Journal:  Immunol Lett       Date:  2000-12-01       Impact factor: 3.685

7.  Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease.

Authors:  D S S Rodrigues; E A S Medeiros; L Y Weckx; W Bonnez; R Salomão; E G Kallas
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

8.  Interactions between Mycobacterium leprae and simian immunodeficiency virus (SIV) in rhesus monkeys.

Authors:  B J Gormus; M Murphey-Corb; G B Baskin; K Uherka; L N Martin; P A Marx; K Xu; M S Ratterree
Journal:  J Med Primatol       Date:  2000-08       Impact factor: 0.667

9.  Enhanced HIV expression during Th2-oriented responses explained by the opposite regulatory effect of IL-4 and IFN-gamma of fusin/CXCR4.

Authors:  G Galli; F Annunziato; C Mavilia; P Romagnani; L Cosmi; R Manetti; C Pupilli; E Maggi; S Romagnani
Journal:  Eur J Immunol       Date:  1998-10       Impact factor: 5.532

10.  Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens.

Authors:  N Kadowaki; S Ho; S Antonenko; R W Malefyt; R A Kastelein; F Bazan; Y J Liu
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

View more
  4 in total

1.  Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients.

Authors:  Karina I Carvalho; Fernanda R Bruno; Jennifer E Snyder-Cappione; Solange M Maeda; Jane Tomimori; Marilia B Xavier; Patrick A Haslett; Douglas F Nixon; Esper G Kallas
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

2.  Evaluation of cellular phenotypes implicated in immunopathogenesis and monitoring immune reconstitution inflammatory syndrome in HIV/leprosy cases.

Authors:  Carmem Beatriz Wagner Giacoia-Gripp; Anna Maria Sales; José Augusto da Costa Nery; Joanna Reis Santos-Oliveira; Ariane Leite de Oliveira; Euzenir Nunes Sarno; Mariza Gonçalves Morgado
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

3.  Leprosy as immune reconstitution inflammatory syndrome in patients living with HIV: Description of French Guiana's cases over 20 years and systematic review of the literature.

Authors:  Alice Mouchard; Romain Blaizot; Jenna Graille; Pierre Couppié; Chloé Bertin
Journal:  PLoS Negl Trop Dis       Date:  2022-03-04

4.  New Players in the Same Old Game: Disturbance of Group 2 Innate Lymphoid Cells in HIV-1 and Mycobacterium leprae Co-infected Patients.

Authors:  Pedro Henrique Papotto; Solange Maeda; Jane Tomimori; Marília Brasil Xavier; Luiz Vicente Rizzo; Esper Georges Kallas; Karina Inácio Carvalho
Journal:  PLoS Negl Trop Dis       Date:  2015-09-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.